Neuropace, Inc. NPCE Deferred Tax Liabilities, Operating Lease Right-of-Use Asset
Deferred Tax Liabilities, Operating Lease Right-of-Use Asset at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept npce:DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset.
The official record: Neuropace, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s deferred tax liabilities, operating lease right-of-use asset.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s deferred tax liabilities, operating lease right-of-use asset?
- Neuropace, Inc. (NPCE) reported deferred tax liabilities, operating lease right-of-use asset of $2.61M in Q4 2025.
- How has Neuropace, Inc.'s deferred tax liabilities, operating lease right-of-use asset changed year-over-year?
- Neuropace, Inc.'s deferred tax liabilities, operating lease right-of-use asset decreased by 13.5% year-over-year, from $3.01M to $2.61M.
- What does deferred tax liabilities, operating lease right-of-use asset mean?
- This metric represents the deferred tax liability arising from the difference between the carrying amount of operating lease right-of-use assets and their tax basis. It reflects the future tax consequences of the company's leasing arrangements as the assets are amortized. Investors monitor this to understand the tax implications of the company's real estate and equipment leasing strategy.